These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

299 related items for PubMed ID: 8963630

  • 41. A clinical, histopathological and flow cytometric study of 149 complete moles, 146 partial moles and 107 non-molar hydropic abortions.
    Paradinas FJ, Browne P, Fisher RA, Foskett M, Bagshawe KD, Newlands E.
    Histopathology; 1996 Feb; 28(2):101-10. PubMed ID: 8834517
    [Abstract] [Full Text] [Related]

  • 42. Fractal geometric analysis of material from molar and non-molar pregnancies.
    Cross SS, Howat AJ, Stephenson TJ, Cotton DW, Underwood JC.
    J Pathol; 1994 Jun; 173(2):115-8. PubMed ID: 8089805
    [Abstract] [Full Text] [Related]

  • 43. Ploidy and imprinting in hydatidiform moles. Complementary use of flow cytometry and immunohistochemistry of the imprinted gene product p57KIP2 to assist molar classification.
    Genest DR, Dorfman DM, Castrillon DH.
    J Reprod Med; 2002 May; 47(5):342-6. PubMed ID: 12063872
    [Abstract] [Full Text] [Related]

  • 44. Utility of fluorescence in situ hybridization for ploidy and p57 immunostaining in discriminating hydatidiform moles.
    Chen KH, Hsu SC, Chen HY, Ng KF, Chen TC.
    Biochem Biophys Res Commun; 2014 Apr 04; 446(2):555-60. PubMed ID: 24613849
    [Abstract] [Full Text] [Related]

  • 45. Inhibin/activin subunits are immunohistochemically expressed in complete and partial hydatidiform moles.
    Mylonas I, Shabani N, Vogl J, Makovitzky J, Kunze S, Kuhn C, Schulze S, Friese K, Jeschke U.
    Anticancer Res; 2007 Apr 04; 27(4A):1995-2000. PubMed ID: 17649811
    [Abstract] [Full Text] [Related]

  • 46. Ploidy analysis by flow cytometry and fluorescence in situ hybridization in hydropic placentas and gestational trophoblastic disease.
    Cheville JC, Greiner T, Robinson RA, Benda JA.
    Hum Pathol; 1995 Jul 04; 26(7):753-7. PubMed ID: 7628847
    [Abstract] [Full Text] [Related]

  • 47. Complete hydatidiform mole. Comparison of clinicopathologic features, current and past.
    Mosher R, Goldstein DP, Berkowitz R, Bernstein M, Genest DR.
    J Reprod Med; 1998 Jan 04; 43(1):21-7. PubMed ID: 9475145
    [Abstract] [Full Text] [Related]

  • 48. Matrix metalloproteinases and their inhibitors in gestational trophoblastic diseases and normal placenta.
    Vegh GL, Selcuk Tuncer Z, Fulop V, Genest DR, Mok SC, Berkowitz RS.
    Gynecol Oncol; 1999 Nov 04; 75(2):248-53. PubMed ID: 10525381
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Diagnosis of hydatidiform moles by polymorphic deletion probe fluorescence in situ hybridization.
    Chiang S, Fazlollahi L, Nguyen A, Betensky RA, Roberts DJ, Iafrate AJ.
    J Mol Diagn; 2011 Jul 04; 13(4):406-15. PubMed ID: 21704275
    [Abstract] [Full Text] [Related]

  • 54. The role of deoxyribonucleic acid image cytometric and interphase cytogenetic analyses in the differential diagnosis, prognosis, and clinical follow-up of hydatidiform moles. A report from the Central Molar Registration in The Netherlands.
    van de Kaa CA, Schijf CP, de Wilde PC, Hanselaar AG, Vooijs PG.
    Am J Obstet Gynecol; 1997 Nov 04; 177(5):1219-29. PubMed ID: 9396922
    [Abstract] [Full Text] [Related]

  • 55. A study of human leukocyte antigen G expression in hydatidiform moles.
    Goldman-Wohl D, Ariel I, Greenfield C, Hochner-Celnikier D, Lavy Y, Yagel S.
    Am J Obstet Gynecol; 2001 Aug 04; 185(2):476-80. PubMed ID: 11518912
    [Abstract] [Full Text] [Related]

  • 56. Do nontriploid partial hydatidiform moles exist? A histologic and flow cytometric reevaluation of nontriploid specimens.
    Genest DR, Ruiz RE, Weremowicz S, Berkowitz RS, Goldstein DP, Dorfman DM.
    J Reprod Med; 2002 May 04; 47(5):363-8. PubMed ID: 12068831
    [Abstract] [Full Text] [Related]

  • 57. Complete hydatidiform mole with retained maternal chromosomes 6 and 11.
    McConnell TG, Norris-Kirby A, Hagenkord JM, Ronnett BM, Murphy KM.
    Am J Surg Pathol; 2009 Sep 04; 33(9):1409-15. PubMed ID: 19542869
    [Abstract] [Full Text] [Related]

  • 58. Refining the diagnosis of hydatidiform mole: image ploidy analysis and p57KIP2 immunohistochemistry.
    Crisp H, Burton JL, Stewart R, Wells M.
    Histopathology; 2003 Oct 04; 43(4):363-73. PubMed ID: 14511255
    [Abstract] [Full Text] [Related]

  • 59. Placental Fas and Fas ligand expression in normal early, term and molar pregnancy.
    Pongcharoen S, Searle RF, Bulmer JN.
    Placenta; 2004 Apr 04; 25(4):321-30. PubMed ID: 15028424
    [Abstract] [Full Text] [Related]

  • 60. Immunohistochemical analysis of c-erbB-2, Bcl-2, p53, p21WAF1/Cip1, p63 and Ki-67 expression in hydatidiform moles.
    Missaoui N, Landolsi H, Mestiri S, Essakly A, Abdessayed N, Hmissa S, Mokni M, Yacoubi MT.
    Pathol Res Pract; 2019 Mar 04; 215(3):446-452. PubMed ID: 30558966
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.